| Preface | ix |
Chapter 1 | Approach to the Patient | 1 |
Chapter 2 | Supportive Care: Antimicrobials, Catheters, and Pain Control | 9 |
Chapter 3 | Pharmacology and Toxicity of Antineoplastic Drugs | 19 |
Chapter 4 | Classification of Red Cell Disorders | 27 |
Chapter 5 | Aplastic Anemia | 29 |
Chapter 6 | Pure Red Cell Aplasia | 33 |
Chapter 7 | Anemia of Chronic Renal Failure | 37 |
Chapter 8 | Anemia of Endocrine Disorders | 39 |
Chapter 9 | Congenital Dyserythropoietic Anemias | 41 |
Chapter 10 | The Megaloblastic Anemias | 45 |
Chapter 11 | Iron Deficiency Anemia | 55 |
Chapter 12 | Anemia Resulting from Other Nutritional Deficiencies | 61 |
Chapter 13 | Disorders of Iron Storage and Transport | 65 |
Chapter 14 | Hereditary and Acquired Sideroblastic Anemias | 69 |
Chapter 15 | Anemia Resulting from Marrow Infiltration | 73 |
Chapter 16 | Anemia of Chronic Disease | 75 |
Chapter 17 | Hereditary Spherocytosis, Elliptocytosis, and Related Disorders | 77 |
Chapter 18 | Hemolytic Anemia Related to Red Cell Enzyme Defects | 87 |
Chapter 19 | The Thalassemias | 91 |
Chapter 20 | The Sickle Cell Diseases and Related Disorders | 99 |
Chapter 21 | Hemoglobinopathies Associated with Unstable Hemoglobin | 107 |
Chapter 22 | Methemoglobinemia and Other Causes of Cyanosis | 109 |
Chapter 23 | Traumatic Hemolytic Anemia, March Hemoglobinuria, Sports and Space-Related Anemia | 113 |
Chapter 24 | Microangiopathic Hemolytic Anemia | 117 |
Chapter 25 | Hemolytic Anemia Resulting from a Physical or Chemical Agent | 121 |
Chapter 26 | Hemolytic Anemia Resulting from Infectious Agents | 123 |
Chapter 27 | Hemolytic Anemia Resulting from Warm-Reacting Antibodies | 127 |
Chapter 28 | Cryopathic Hemolytic Anemia | 133 |
Chapter 29 | Drug-Induced Hemolytic Anemia | 137 |
Chapter 30 | Alloimmune Hemolytic Disease of the Newborn | 143 |
Chapter 31 | Acute Blood Loss Anemia | 147 |
Chapter 32 | Hypersplenism and Hyposplenism | 149 |
Chapter 33 | The Polycythemias | 155 |
Chapter 34 | Hematologic Aspects of the Porphyrias | 165 |
Chapter 35 | Classification and Clinical Manifestations of Neutrophil Disorders | 173 |
Chapter 36 | Neutropenia and Neutrophilia | 179 |
Chapter 37 | Qualitative Disorders of Neutrophils | 189 |
Chapter 38 | Eosinophils and Their Diseases | 199 |
Chapter 39 | Basophils and Mast Cells and Their Diseases | 205 |
Chapter 40 | Monocytosis and Monocytopenia | 209 |
Chapter 41 | Inflammatory and Malignant Histiocytosis | 211 |
Chapter 42 | Lipid Storage Disease | 217 |
Chapter 43 | Classification and Clinical Manifestations of the Clonal Myeloid Disorders | 221 |
Chapter 44 | Clonal Cytopenias and Oligoblastic Leukemias (Myelodysplasias) | 229 |
Chapter 45 | Paroxysmal Nocturnal Hemoglobinuria (PNH) | 233 |
Chapter 46 | The Acute Myelogenous Leukemias | 237 |
Chapter 47 | The Chronic Myelogenous Leukemias | 249 |
Chapter 48 | Idiopathic Myelofibrosis (Agnogenic Myeloid Metaplasia) | 259 |
Chapter 49 | Classification of the Benign Lymphoid Disorders | 265 |
Chapter 50 | Lymphocytosis and Lymphocytopenia | 269 |
Chapter 51 | Primary Immunodeficiency Syndrome | 275 |
Chapter 52 | The Acquired Immunodeficiency Syndrome | 279 |
Chapter 53 | The Mononucleosis Syndromes | 289 |
Chapter 54 | Classification and Clinical Manifestations of the Malignant Lymphoid Disorders | 295 |
Chapter 55 | The Acute Lymphocytic Leukemias | 303 |
Chapter 56 | The Chronic Lymphocytic Leukemias | 315 |
Chapter 57 | Hairy Cell Leukemia | 327 |
Chapter 58 | Large Granular Lymphocytic Leukemia | 333 |
Chapter 59 | The Lymphomas | 337 |
Chapter 60 | Hodgkin Lymphoma | 353 |
Chapter 61 | The Monoclonal Gammopathies and Plasma Cell Dyscrasias | 361 |
Chapter 62 | Myeloma | 367 |
Chapter 63 | Macroglobulinemia | 377 |
Chapter 64 | Heavy-Chain Diseases | 381 |
Chapter 65 | Amyloidosis | 383 |
Chapter 66 | Clinical Manifestations, Evaluation, and Classification of Disorders of Hemostasis | 387 |
Chapter 67 | The Thrombocytopenias | 395 |
Chapter 68 | Essential Thrombocythemia and Thrombocytosis | 415 |
Chapter 69 | Hereditary Platelet Disorders | 419 |
Chapter 70 | Acquired Platelet Disorders | 429 |
Chapter 71 | The Vascular Purpuras | 435 |
Chapter 72 | Hemophilia A and B | 441 |
Chapter 73 | von Willebrand Disease | 449 |
Chapter 74 | Hereditary Disorders of Fibrinogen | 457 |
Chapter 75 | Inherited Deficiencies of Coagulation Factors II, V, VII, X, XI, and XIII and the Combined Deficiencies of Factors V and VIII and of the Vitamin K-Dependent Factors | 461 |
Chapter 76 | Hemostatic Dysfunction Related to Liver Diseases | 469 |
Chapter 77 | The Antiphospholipid Syndrome (Lupus Anticoagulants and Related Disorders) | 471 |
Chapter 78 | Disseminated Intravascular Coagulation | 475 |
Chapter 79 | Hyperfibrinolysis and Therapy with Antifibrinolytic Agents | 485 |
Chapter 80 | Thrombophilia | 489 |
Chapter 81 | Antiplatelet Therapy | 495 |
Chapter 82 | Anticoagulant Therapy | 499 |
Chapter 83 | Fibrinolytic Therapy | 509 |
Chapter 84 | Transfusion of Blood and Red Cells | 513 |
Chapter 85 | Transfusion of Platelets | 521 |
Chapter 86 | Therapeutic Hemapheresis | 525 |
| Table of Normal Values | 529 |
| Index | 533 |